Oxygen in interstitial lung diseases

Area of Science:

• Pulmonary Medicine
• Respiratory Care

Background:

• Domiciliary oxygen is crucial for hypoxemic interstitial lung disease (ILD) patients.
• Current guidelines recommend long-term oxygen therapy (LTOT) for severe resting hypoxemia in ILD, with potential survival benefits extrapolated from COPD.
• Pulmonary hypertension (PH) and right heart failure necessitate a lower hypoxemia threshold for LTOT initiation.

Purpose of the Study:

• To review the current evidence and guidelines for domiciliary oxygen therapy in ILD.
• To highlight the need for further research into nocturnal oxygen and ambulatory oxygen therapy (AOT).
• To identify challenges and unmet needs in oxygen delivery systems for ILD patients.

Main Methods:

• Literature review of existing guidelines and studies on oxygen therapy in ILD.
• Analysis of evidence regarding resting, nocturnal, and exertional hypoxemia.
• Discussion of the impact of oxygen therapy on quality of life, exercise tolerance, and survival.

Main Results:

• LTOT is recommended for severe resting hypoxemia in ILD, with potential benefits for breathlessness, disability, and survival.
• Nocturnal hypoxemia's link to PH and poor survival warrants urgent investigation.
• AOT shows promise for exertional hypoxemia, improving quality of life, though evidence is limited and guidelines vary.

Conclusions:

• Domiciliary oxygen therapy, including LTOT and AOT, plays a vital role in managing hypoxemic ILD.
• Further research is essential to optimize oxygen use, particularly for nocturnal and exertional hypoxemia.
• Development of improved oxygen delivery systems is needed to mitigate patient burden and enhance AOT effectiveness.